Participant Experience


Ranked among the highest-rated Harvard Medical School CME courses, past participants consistently report that this program has inspired and improved their clinical practice and outcomes. Here are a number of comments from recent attendees:

Dear Dr. Basgoz,

I write to say "Brava!" . ...This year's course satisfied my three criteria for a substantive educational experience:

  1. ​New and meaningful information on topics that I don't know much about (e.g., transplant ID)
  2. New and meaningful information on topics in which I have a good deal of expertise (e.g., bone and joint infections, tick-borne illness)
  3. Not falling asleep in any of the lectures!

Once again, kudos to you and Drs. Calderwood, Gandhi, and Nelson on a job well done.


“This course not only helped me polish my clinical approach to ID consult, it was the best educational event in my ID career in the last ten years. Very motivating!!”

“The sheer breadth of coverage and the quality of presenters and presentations is unparalleled.”

“I work in transplant (and am a relatively new PA).  The course provided a thorough review of ID, reminded me to broaden differential, and gave me the most up-to-date antibiotic best practices.”

“As a primary care physician, the conference was pivotal in how I now approach and diagnose my patient population.”


“My approach to HIV management, vaccines, ENT and eye care, Herpes viruses, UTIs, and endocarditis have all changed due to this course.”

“It was very helpful and eye-opening to get expert opinions and hear what is being done at MGH in areas of controversy and uncertainties in clinical practice—areas not covered by standard guidelines.”

“Having attended this course, I was able to achieve improvements in differential diagnosis.”

“I see a lot of cellulitis, pneumonia and COPD exacerbation.  I was able to incorporate what was taught in this program to develop more effective protocols for each.”

“I found the updates in HIV care to be particularly influential in determining appropriate ART regimens.”

“The information in this course regarding high-risk patients is invaluable, from when to start antifungal therapy, employ galactomannan testing, and increase use of HPV and shingles vaccines, to looking for Bartonella in culture-negative endocarditis.”

“We were able to improve OPAT in clinical practice.”

“I identified areas where we could improve patient management and how we test and select appropriate antimicrobials.”

“I got state-of-the-art developments for Hepatitis C and STDs.”

“I’ve implemented improved diagnostic approaches, broader differential diagnoses, and expanded immunization and prevention approaches.”

“I sent a list of about 50 pearls I gleaned from this conference to my ID partners.”

“What was the most helpful section of this program? There were actually too many to name, but offhand, the lectures about immunocompromised patients, the vaccine update and the drug review proved to be enormously value to my practice.”

“The presentations on bone infections, tropical medicine, TB, and diagnostics were exceptional and very helpful to my practice.”



“This program has helped me provide better management of patients on biologics and patients who require immunosuppression.”

“I’ve made important changes in the antibiotic choices I choose to treat certain infections and also achieved improvements in antibiotic stewardship.”

“This information helped us to restructure our approach to the immunocompromised patients in our hospital, including bone marrow transplant recipients and biologic therapy recipients, to ensure adequate vaccination, prophylaxis and early diagnosis and treatment of the possible infections that occur after immunocompromise.”

“We changed some key formulary and lab practices at my hospital as well as our pre-immunosuppression exams.”

“In my facility we have many solid organ transplants. The sessions that dealt with infectious disease in immunocompromised patients was very timely and extremely helpful.”

“I work at the ER, where I was able to immediately apply the new information that was given to me on rabies, HCV, and HIV.”



“After attending, I changed my first line treatment for uncomplicated cystitis. We now carefully consider more rigorous vaccination, different testing methods for STDs, and additional infectious disease screening for homeless and multicultural populations.”

“I am now much more knowledgeable about treatment of and patient counseling for zoonoses, including rabies vaccines.”

“I gained an awareness of certain issues that as a general internist in a rural area I might have overlooked, specifically in STD and acute HIV, so I now test a bit more than I previously had in certain situations.”

“As a general internist, I got important updates regarding a number of the diseases that I see on a regular basis.”